Technology
Health
Biotechnology

Capricor

$5.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-1.33%) As of 2:34 PM EDT today
-$0.08 (-1.33%) Today

Why Robinhood?

You can buy or sell Capricor and other stocks, options, ETFs, and crypto commission-free!

About CAPR

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. Read More The company was founded in August 2005 and is headquartered in Beverly Hills, CA.

Employees
22
Headquarters
Beverly Hills, California
Founded
2005
Market Cap
20.20M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
184.80K
High Today
$7.35
Low Today
$5.63
Open Price
$6.33
Volume
3.32M
52 Week High
$14.60
52 Week Low
$2.53

Collections

Technology
Health
Biotechnology
Therapy
Medical
US
North America
Female CEOs

CAPR News

BenzingaJul 15

Why Is Capricor Moving?

2,121

CAPR Earnings

-$0.16
-$0.13
-$0.11
-$0.08
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours

More CAPR News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.